In terms of Rho GTPase regulators, Aleskandarany and colleagues found that the expression of ARHGAP18, a RhoA-specific GAP, is associated with improved prognosis for patients with breast cancer [129]. Here, ARHGAP18 is linked to breast carcinoma.